awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39059946-3968CFDB-983B-4B34-A33F-CEC661A96F86
Q39059946-3968CFDB-983B-4B34-A33F-CEC661A96F86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39059946-3968CFDB-983B-4B34-A33F-CEC661A96F86
Neuropeptide systems and new treatments for nicotine addiction.
P2860
Q39059946-3968CFDB-983B-4B34-A33F-CEC661A96F86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39059946-3968CFDB-983B-4B34-A33F-CEC661A96F86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcd582679e834a7129568ee77ddd1b3e445d4d34
P2860
Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety.